ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 716970 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 716970; 2) Community: the network communities that were significantly associated with the response to NSC 716970; 3) Molecule: the relationships between components within communities and NSC 716970; 4) MDR: the compounds that were significantly associated with the NSC 716970.

NSC Compound Enrichment Correlation
NSC 734148 2-(4-Chloro-benzenesulfonylimino)-imidazolidine-1-carbodithi oic acid 3-thioxo-5,6-dihydro-imidazo[2,1-c][1,2,4] thiadiazol-7-yl ester 0.00550789647802199 0.092618402
NSC 73735 B 3845 0.00550789647802199 0.43174822
NSC 743434 8-(4-{5-[3-(4-fluoro phenyl)-3-oxo-1-prophenyl]-2-methoxy phenoxy}pentoxy)-7-methoxy-2,3,5,11-a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a],[1,4]diazepin-5-one 0.00550789647802199 0.60374126
NSC 116789 Acovenoside B 0.00559873245069072 0.35514807
NSC 132483 Aminopterin Derivative 0.00559873245069072 0.4562801
NSC 137679 9H-Purine-6(1H)-one, 2-amino-9-.beta.-D-ribofuranosyl-6-seleno- 0.00559873245069072 0.22981395
NSC 46598 Null 0.00559873245069072 0.31287232
NSC 615804 ANTINEOPLASTIC-615804 0.00559873245069072 0.28259206
NSC 625737 Null 0.00559873245069072 0.34666412
NSC 643001 3'O-phosphono-(Z)-combretastatin A-4, ammonium salt, hydrate [10:15:4] 0.00559873245069072 0.21545061
Total:95  Current:21    [First] [Prev] [Next] [Last]